Ovid Therapeutics to Present at Upcoming September Investor Conferences
Provided By GlobeNewswire
Last update: Sep 4, 2024
NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to improving the lives of people affected by rare epilepsies and brain conditions, today announced that management will participate in two upcoming investor conferences in September:
